Webinars
Accelerating Your Gene Therapy to Patients: Not All Platforms Are Created Equal
In this fireside chat, George Buchman, Ph.D., Vice President, Pre-Clinical and Process Development, Catalent Cell & Gene Therapy and Thomas VanCott, Ph.D., Chief Scientific Officer, Combined Therapeutics, explore how a complete platform approach to fast-track AAVs can enhance quality and efficiency.
View Now
Article
Article: Streamlining Process Characterization Toward Successful Validation Campaigns
Understanding processes in the development and manufacture of biological drug substances is crucial to successfully navigating the clinical phases towards commercial launch, all within ever‑tightening time constraints, and regulatory frameworks.
View Now
Offering Fact Sheet
UpTempo℠ Antibody Platform Process
Summary: A single solution integrating development through complete clinical supply to simplify, accelerate and de-risk your monoclonal antibody (mAb) development.
View Now
Webinars
Webinar – SMARTag® Technology, from Bertozzi Lab to Best-in-Class ADCs
In this webinar, Chemistry Nobel Laureate, Carolyn Bertozzi, Ph.D., Professor, Stanford University, Penelope Drake, Ph.D., Head of R&D, Bioconjugates, Catalent Biologics, and Seema Kantak, Ph.D., Senior Vice President, Biotherapeutics, Exelixis, discuss the latest trends in ADC discovery and development.
View Now
Article
The Current State of the Cell Therapy Market: Q&A with Maria Lopez, General Manager, US Cell Therapy at Catalent Biologics
Catalent’s Maria Lopez, General Manager of US Cell Therapy discusses the current state of the cell therapy market and the ways Catalent is working to overcome some of these challenges. Based on an interview conducted by, and published in, BioBuzz.
View Now
Webinars
Exploring a One-Stop Integrated Solution for AAV Vector Clinical Production
Learn how the right process, clonal HEK293 cell line, and range of off-the-shelf plasmids, along with qualified analytical methods supports a robust supply chain for the development and manufacture of AAV vectors, and the reduction of timelines to clinical evaluation.
View Now
Webinars
GMP Process for High-Quality iPSC Manufacturing and Development of Improved Differentiation Methodologies
In this webinar, experts will discuss the evolution of protocols associated with induced pluripotent stem cell generation and differentiation.
View Now
Executive Summary
Early Phase Support for Plasmid DNA Supply to Secure Future Manufacturing
Summary: One significant challenge in the manufacturing of cell and gene therapies is the production of high quality plasmid DNA (pDNA). pDNA is a critical raw material for advanced therapeutics including mRNA and viral vector-based cell and gene therapies and vaccines.
View Now
Webinars
Webinar – Process Optimization for Monoclonal Antibody (mAb) Commercial Manufacturing
In this webinar, experts will discuss the evolution of protocols associated with induced pluripotent stem cell (iPSC) generation and differentiation.
View Now
Webinars
Webinar – Overcoming Formulation Challenges for mRNA and High-Concentration Proteins
In this webinar, experts will discuss how to improve the formulation development of high-concentration mAbs for subcutaneous delivery to reduce viscosity, and potentially reduce costs and timelines, and how to overcome current challenges met in formulating mRNA lipid nanoparticles (mRNA-LNP).
View Now
